Sushil Patel
Chief Executive Officer at Replimune Group Inc.
Sits on 2 boards. Last updated September 27, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Revolution Medicines Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Revolution Medicines Inc. June 26, 202585.5%
-
Replimune Group Inc. September 4, 202499.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 10, 2026 | Replimune Group Inc. | Open-market sale | −39,341 | $12.97 | $510,253 |
| Jun 29, 2026 | Revolution Medicines Inc. | Option exercise | +2,955 | $37.54 | $110,931 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −300 | $183.17 | $54,952 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −900 | $184.59 | $166,128 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −1,100 | $185.90 | $204,489 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −858 | $186.92 | $160,374 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −300 | $187.83 | $56,348 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −100 | $188.57 | $18,857 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −600 | $190.55 | $114,327 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −541 | $191.87 | $103,800 |
| Jun 29, 2026 | Revolution Medicines Inc. | Open-market sale | −881 | $192.61 | $169,693 |
| Jun 18, 2026 | Revolution Medicines Inc. | Grant or award | +1,191 | — | — |
| May 18, 2026 | Replimune Group Inc. | Open-market sale | −37,324 | $5.08 | $189,606 |
| Apr 1, 2026 | Replimune Group Inc. | Grant or award | +251,240 | — | — |
| Dec 19, 2025 | Replimune Group Inc. | Grant or award | +200,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.